F
The startup develops live biotherapeutics using safe bacterial products to treat gastrointestinal inflammation, including inflammatory bowel disease and irritable bowel syndrome, in both humans and animals. By providing natural alternatives to traditional medications, the company aims to reduce the negative side effects associated with conventional treatments.
Updated 18 months ago
Funding
$330K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
DC
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops live biotherapeutics using safe bacterial products to treat gastrointestinal inflammation, including inflammatory bowel disease and irritable bowel syndrome, in both humans and animals. By providing natural alternatives to traditional medications, the company aims to reduce the negative side effects associated with conventional treatments.